vs
辉瑞（PFE）与Smurfit Westrock（SW）财务数据对比。点击上方公司名可切换其他公司
辉瑞的季度营收约是Smurfit Westrock的1.9倍（$14.5B vs $7.7B），辉瑞净利率更高（18.6% vs 0.8%，领先17.8%），辉瑞同比增速更快（5.0% vs 0.7%），过去两年Smurfit Westrock的营收复合增速更高（61.2% vs 4.3%）
辉瑞是总部位于美国纽约曼哈顿The Spiral的跨国制药及生物技术企业，由德国企业家查尔斯·辉瑞与查尔斯·F·埃尔哈特于1849年在纽约创立，是北美地区历史最悠久的制药企业之一，在全球医药健康领域拥有较高的行业影响力。
Smurfit Westrock plc是总部位于爱尔兰都柏林的企业，核心业务为生产瓦楞包装及各类纸制包装产品，公司股票同时在纽约证券交易所和伦敦证券交易所挂牌上市。
PFE vs SW — 直观对比
营收规模更大
PFE
是对方的1.9倍
$7.7B
营收增速更快
PFE
高出4.3%
0.7%
净利率更高
PFE
高出17.8%
0.8%
两年增速更快
SW
近两年复合增速
4.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $14.5B | $7.7B |
| 净利润 | $2.7B | $63.0M |
| 毛利率 | — | 16.4% |
| 营业利润率 | — | 3.3% |
| 净利率 | 18.6% | 0.8% |
| 营收同比 | 5.0% | 0.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.47 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PFESW
| Q1 26 | $14.5B | $7.7B | ||
| Q4 25 | $17.6B | $7.6B | ||
| Q3 25 | $16.7B | $8.0B | ||
| Q2 25 | $14.7B | $7.9B | ||
| Q1 25 | $13.7B | $7.7B | ||
| Q4 24 | $17.8B | $7.5B | ||
| Q3 24 | $17.7B | $7.7B | ||
| Q2 24 | $13.3B | $3.0B |
净利润PFESW
| Q1 26 | $2.7B | $63.0M | ||
| Q4 25 | $-1.6B | $97.0M | ||
| Q3 25 | $3.5B | $246.0M | ||
| Q2 25 | $2.9B | $-28.0M | ||
| Q1 25 | $3.0B | $384.0M | ||
| Q4 24 | $410.0M | $146.0M | ||
| Q3 24 | $4.5B | $-150.0M | ||
| Q2 24 | $41.0M | $132.0M |
毛利率PFESW
| Q1 26 | — | 16.4% | ||
| Q4 25 | 70.0% | 18.2% | ||
| Q3 25 | 74.9% | 19.6% | ||
| Q2 25 | 74.2% | 19.1% | ||
| Q1 25 | 79.3% | 20.6% | ||
| Q4 24 | 66.7% | 19.1% | ||
| Q3 24 | 70.3% | 17.6% | ||
| Q2 24 | 75.2% | 23.3% |
营业利润率PFESW
| Q1 26 | — | 3.3% | ||
| Q4 25 | -9.4% | 5.1% | ||
| Q3 25 | 20.0% | 6.6% | ||
| Q2 25 | 20.8% | 3.2% | ||
| Q1 25 | 20.3% | 7.2% | ||
| Q4 24 | -0.1% | 5.3% | ||
| Q3 24 | 26.6% | 0.7% | ||
| Q2 24 | -0.8% | 8.2% |
净利率PFESW
| Q1 26 | 18.6% | 0.8% | ||
| Q4 25 | -9.4% | 1.3% | ||
| Q3 25 | 21.3% | 3.1% | ||
| Q2 25 | 19.9% | -0.4% | ||
| Q1 25 | 21.6% | 5.0% | ||
| Q4 24 | 2.3% | 1.9% | ||
| Q3 24 | 25.2% | -2.0% | ||
| Q2 24 | 0.3% | 4.4% |
每股收益（稀释后）PFESW
| Q1 26 | $0.47 | $0.12 | ||
| Q4 25 | $-0.29 | $0.18 | ||
| Q3 25 | $0.62 | $0.47 | ||
| Q2 25 | $0.51 | $-0.05 | ||
| Q1 25 | $0.52 | $0.73 | ||
| Q4 24 | $0.07 | $-0.12 | ||
| Q3 24 | $0.78 | $-0.30 | ||
| Q2 24 | $0.01 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $980.0M |
| 股东权益账面价值 | — | $18.1B |
| 总资产 | — | $45.2B |
| 负债/权益比越低杠杆越低 | — | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资PFESW
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $892.0M | ||
| Q3 25 | $1.3B | $851.0M | ||
| Q2 25 | $1.6B | $778.0M | ||
| Q1 25 | $1.4B | $797.0M | ||
| Q4 24 | $1.0B | $855.0M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | $26.8K |
总债务PFESW
| Q1 26 | — | $980.0M | ||
| Q4 25 | — | $13.4B | ||
| Q3 25 | — | $13.3B | ||
| Q2 25 | — | $13.3B | ||
| Q1 25 | — | $12.9B | ||
| Q4 24 | — | $12.5B | ||
| Q3 24 | — | $13.2B | ||
| Q2 24 | — | — |
股东权益PFESW
| Q1 26 | — | $18.1B | ||
| Q4 25 | $86.5B | $18.3B | ||
| Q3 25 | $92.8B | $18.4B | ||
| Q2 25 | $88.7B | $18.3B | ||
| Q1 25 | $90.3B | $17.9B | ||
| Q4 24 | $88.2B | $17.4B | ||
| Q3 24 | $92.3B | $18.0B | ||
| Q2 24 | $87.7B | $14.5K |
总资产PFESW
| Q1 26 | — | $45.2B | ||
| Q4 25 | $208.2B | $45.2B | ||
| Q3 25 | $208.7B | $45.6B | ||
| Q2 25 | $206.1B | $45.7B | ||
| Q1 25 | $208.0B | $44.6B | ||
| Q4 24 | $213.4B | $43.8B | ||
| Q3 24 | $219.5B | $45.0B | ||
| Q2 24 | $216.2B | $26.8K |
负债/权益比PFESW
| Q1 26 | — | 0.05× | ||
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 0.72× | ||
| Q4 24 | — | 0.72× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $204.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.24× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PFESW
| Q1 26 | — | $204.0M | ||
| Q4 25 | $5.3B | $1.2B | ||
| Q3 25 | $4.6B | $1.1B | ||
| Q2 25 | $-582.0M | $829.0M | ||
| Q1 25 | $2.3B | $235.0M | ||
| Q4 24 | $6.7B | $781.0M | ||
| Q3 24 | $6.7B | $320.0M | ||
| Q2 24 | $-1.8B | $340.0M |
自由现金流PFESW
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $612.0M | ||
| Q3 25 | $4.0B | $523.0M | ||
| Q2 25 | $-1.2B | $307.0M | ||
| Q1 25 | $1.8B | $-242.0M | ||
| Q4 24 | $5.8B | $212.0M | ||
| Q3 24 | $6.1B | $-192.0M | ||
| Q2 24 | $-2.4B | $163.0M |
自由现金流率PFESW
| Q1 26 | — | — | ||
| Q4 25 | 25.6% | 8.1% | ||
| Q3 25 | 24.0% | 6.5% | ||
| Q2 25 | -8.2% | 3.9% | ||
| Q1 25 | 12.9% | -3.2% | ||
| Q4 24 | 32.7% | 2.8% | ||
| Q3 24 | 34.3% | -2.5% | ||
| Q2 24 | -18.2% | 5.5% |
资本支出强度PFESW
| Q1 26 | — | — | ||
| Q4 25 | 4.8% | 7.7% | ||
| Q3 25 | 3.6% | 7.6% | ||
| Q2 25 | 4.2% | 6.6% | ||
| Q1 25 | 4.1% | 6.2% | ||
| Q4 24 | 5.2% | 7.5% | ||
| Q3 24 | 3.7% | 6.7% | ||
| Q2 24 | 4.8% | 6.0% |
现金转化率PFESW
| Q1 26 | — | 3.24× | ||
| Q4 25 | — | 12.32× | ||
| Q3 25 | 1.30× | 4.61× | ||
| Q2 25 | -0.20× | — | ||
| Q1 25 | 0.79× | 0.61× | ||
| Q4 24 | 16.39× | 5.35× | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | -43.44× | 2.58× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PFE
| Product revenues | $11.7B | 81% |
| Alliance revenues | $2.3B | 16% |
| Royalty revenues | $396.0M | 3% |
SW
暂无分部数据
